Home › Calculator › DTCFF Dividend Calculator 2026
DTCFF Dividend DRIP Calculator 2026
580.72% YieldHealthcareDefence Therapeutics Inc. · OTC
Price: $0.34 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When DTCFF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your DTCFF snowball 📈
$10,000 in DTCFF → $2136415.40M in 10 years · $151,880,751,094.78/month
About Defence Therapeutics Inc. (DTCFF) — Dividend Analysis 2026
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology, including antibody drug conjugates targeting various cancers; the anti-cancer AccuTOX program, which has completed preclinical studies for solid T-cell lymphoma, breast cancer, and melanoma; the ARM-X vaccine program, a mesenchymal stem cell-based vaccine targeting cancer; and mRNA vaccination program. The company also offers Dendritic Cell (DC) cancer vaccines using Accum; a protein-based vaccine formulation against COVID and infectious diseases; and a cervical cancer vaccine. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Montreal, Canada.
Compare DTCFF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full DTCFF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open DTCFF position with:
🌍 DTCFF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold DTCFF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 580.72% | 577.92% | $58,072 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 493.61% | 490.81% | $49,361 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 464.58% | 461.78% | $46,458 / yr |
| 🇬🇧 UK ISA | 0% | 580.72% | 577.92% | $58,072 / yr |
| 🇬🇧 UK Taxable | 8.75% | 529.91% | 527.11% | $52,991 / yr |
| 🇨🇦 TFSA | 0% | 580.72% | 577.92% | $58,072 / yr |
| 🇨🇦 CA Taxable | 25% | 435.54% | 432.74% | $43,554 / yr |
| 🇦🇺 Super (pension) | 15% | 493.61% | 490.81% | $49,361 / yr |
| 🇦🇺 AU Taxable | 30% | 406.50% | 403.70% | $40,650 / yr |
| 🇩🇪 DE Taxable | 26.375% | 427.56% | 424.76% | $42,756 / yr |
| 🇫🇷 FR Taxable | 30% | 406.50% | 403.70% | $40,650 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 DTCFF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 DTCFF Dividend Payment Schedule
DTCFF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 DTCFF vs Healthcare Benchmarks
How DTCFF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for DTCFF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ DTCFF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the DTCFF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Defence Therapeutics Inc. (DTCFF) is currently trading at $0.34, 95% below its 52-week high. The current dividend yield is 580.72% based on an annual payout of $2.00 per share.
DTCFF (Defence Therapeutics Inc.) — 580.72% Dividend Yield Analysis
Defence Therapeutics Inc. (DTCFF) is a healthcare stock currently trading at $0.34 with a dividend yield of 580.72%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (580.72%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest DTCFF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.